Register
Login:
Share:
Email Facebook Twitter

RNS VIDEO: Reabold Resources #RBD raise £6 million and take stake in Danube Petroleum Watch here

EXCLUSIVE: HemoGenyx are creating blood cancer treatments with US$9 billion market potential


Abzena Share Price (ABZA)



Share Price Information for Abzena (ABZA)


Share Price: 33.50Bid: 33.00Ask: 34.00Change: 1.00 (+3.08%)Riser - Abzena
Spread: 1.00Spread as %: 3.03%Open: 33.50High: 33.50Low: 33.50Yesterday’s Close: 32.50

Abzena Plc Ord Gbp0.002

Abzena is listed in the FTSE AIM All-Share
Abzena is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
33.50

Share Price SpacerBid
33.00

Share Price SpacerAsk
34.00

Share Price SpacerChange
3.08%1.00

Share Price SpacerVolume
64,939

Share Price SpacerOpen
33.50

Share Price SpacerHigh
33.50

Share Price SpacerLow
33.50

Share Price SpacerClose
32.50

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 213.64m £71.57m 5,000

52 Week High 64.00 52 Week High Date 20-JAN-2017
52 Week Low 27.50 52 Week Low Date 30-OCT-2017

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
7 40,591 16,904 -4.786 -7.00 0.00 0.00


London South East Users info for Abzena




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

12-Dec-17
11:02:33
32.10
25,000
Sell* 
33.00
34.00
8,025
Trade Type:
Ordinary

12-Dec-17
09:53:21
33.41
3,591
Sell* 
33.00
34.00
1,200
Trade Type:
Ordinary

12-Dec-17
09:48:23
33.50
7,444
 
33.00
34.00
2,494
Trade Type:
Ordinary




View more Abzena trades >>

Directors Deals for Abzena (ABZA)
Trade DateActionNotifierPriceCurrencyAmountHolding
10-Apr-17Transfer To
Trade Notifier Information for Abzena
Peter Grant held the position of Non-Executive Director at Abzena at the time of this trade.
 Peter Grant
33GBX25,00058303
16-Aug-16Exercise of option
Trade Notifier Information for Abzena
Anker Lundemose held the position of Non-Executive Director at Abzena at the time of this trade.
 Anker Lundemose
0.02GBX75,00075000
27-Jun-16Transfer To
Trade Notifier Information for Abzena
John Burt held the position of CEO at Abzena at the time of this trade.
 John Burt
41GBX98,0002120262
View more Abzena directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Mon 19:43RayofhopeCurious why..32.50No Opinion
Directors don’t have more of a holding.

Assuming the Taiwan and/or US deals pan out, getting involved at this price has potential but the above is a puzzle.

Any thoughts from LTH’s who have a reasoned view?
Mon 07:14AC34RNS31.50No Opinion
Nice little service contract ! Results due soon !
8 Nov '17JFK8TR131.50No Opinion
Notification
27 Sep '17KnowbodyyouknowBuy or sell @ 12.01?33.50No Opinion
Be interesting to know.
Presumably a buy, given the price.
19 Sep '17KnowbodyyouknowAhhh34.25No Opinion
No.

Just done some more research.

Seems Canaccord Genuity have completed their acquisition of Hargreaves Hale:

http://www.newswire.ca/news-releases/canaccord-genuity-wealth-management-in-the-uk--europe-completes-acquisition-of-hargreave-hale-limited-645348913.html
19 Sep '17KnowbodyyouknowCanaccord Genuity34.25No Opinion
Have they just bought Hargreaves Hale's stake here?

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Abzena (ABZA) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.